drug · gene
afamitresgene autoleucel
Phase 2updated 3mo agoby US WorldMeds LLC🔗 ChEMBL
Phase 2community read0 votes
Gene drug with a maximum clinical stage of Approval (across all indications), with an approval for synovial sarcoma and 2 investigational indications.
targets
Melanoma-associated antigen 4
all catalysts(0)
nothing on the calendar yet
Trials studying afamitresgene autoleucel
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that